¶ Latin American Neurodegeneration Research and Biotech
Latin America has a growing research infrastructure for neurodegenerative disease research, with key centers in Brazil, Argentina, Mexico, and Chile conducting important studies on Alzheimer's disease, Parkinson's disease, and related disorders. This page covers the regional research landscape, notable institutions, and emerging biotech opportunities.
- Location: São Paulo, Brazil
- Focus: Funding agency supporting neurodegeneration research
- Notable: One of Latin America's largest research funders
- Website: fapesp.br
- Location: São Paulo, Brazil
- Focus: Biomedical research, including neuroscience
- Notable: Major vaccine and therapeutics research
- Location: São Paulo, Brazil
- Focus: Neurology and neuroscience research
- Notable: Leading PD research programs in Latin America
- Location: Belo Horizonte, Brazil
- Focus: Tropical diseases, emerging neuroscience research
- Location: Buenos Aires, Argentina
- Focus: Basic and translational neuroscience
- Notable: Strong PD research program
- Location: Buenos Aires, Argentina
- Focus: Neurology and psychiatry research
- Notable: Largest university research system
- Location: Mexico City, Mexico
- Focus: Neurological disorders, including AD and PD
- Notable: National reference center
- Location: Mexico City, Mexico
- Focus: Neuroscience research
- Notable: Largest university in Latin America
- Location: Santiago, Chile
- Focus: Aging and neurodegeneration research
- Notable: Strong basic science program
- Focus: Geriatrics and neurodegeneration
- Members: Researchers from Brazil, Argentina, Mexico, Chile
- Activities: Clinical trials, research networks
- Population: Large elderly population for clinical studies
- Opportunity: Genetic diversity in research
- Challenge: Infrastructure development needed
Latin America hosts numerous clinical trials for neurodegenerative diseases:
| Phase |
AD Trials |
PD Trials |
Location |
| I |
3 |
5 |
Brazil |
| II |
5 |
8 |
Brazil, Argentina |
| III |
10 |
15 |
Multiple |
- Genetic diversity: Unique population genetics
- Large patient pools: Aging populations
- Cost efficiency: Lower trial costs than US/EU
¶ Challenges and Future Directions
- Research funding: Increased government investment needed
- Clinical trial infrastructure: More trial sites needed
- Biotech development: More company formation encouraged
- Regulatory harmonization: Regional regulatory alignment
- Biotech startups: Growing ecosystem in Brazil and Mexico
- Academic spin-outs: Technology transfer from universities
- International partnerships: Collaborations with US/EU centers
Latin American researchers contribute to AD research in several key areas:
- Epidemiology: Population-based studies on prevalence and risk factors
- Genetics: Investigation of unique genetic variants in Latin American populations
- Biomarkers: Development of culturally appropriate cognitive assessments
- Clinical trials: Participation in international Phase II/III trials
The region has strong PD research programs:
- Movement disorders: Specialized centers in São Paulo, Buenos Aires, Mexico City
- Genetics: Studies on LRRK2 and GBA variants in Latin American populations
- Clinical outcomes: Long-term follow-up studies
- Cell therapy: Early research on stem cell approaches
- PSP and CBD: Clinical characterization studies
- Dementia with Lewy Bodies: Growing research interest
- FTD: Emerging programs in major centers
¶ Technology Transfer and Innovation
Several Latin American universities are developing technology transfer offices to commercialize research:
- USP Innovation Agency: Technology transfer office at University of São Paulo
- UNAM Innovation: Technology transfer at Universidad Nacional Autónoma de México
- CONICET: Argentine research council technology transfer programs
¶ Incubators and Accelerators
- Innova BR: Brazilian biotech incubator
- M指定BIO: Mexican life sciences accelerator
- Start-up Chile: Innovation support program
¶ Funding Landscape
| Country |
Funding Agency |
Focus |
| Brazil |
FAPESP, CNPq |
Basic and clinical research |
| Argentina |
CONICET |
Basic science |
| Mexico |
CONACYT |
Applied research |
| Chile |
ANID |
Innovation |
- Fogarty International: NIH funding for Latin American neuroscience
- European Union: Horizon America research partnerships
- World Health Organization: Regional neurology initiatives
¶ Training and Education
- Master's programs: Neuroscience and neurology in major universities
- PhD programs: Collaborative programs with international institutions
- Clinical fellowships: Movement disorders specialization
- Fellowships abroad: Latin American neurologists train at US/EU centers
- Exchange programs: Student and researcher mobility
- Conference attendance: Regional meetings and international conferences
Latin America represents an emerging hub for neurodegeneration research with significant potential. The region's large and aging population, growing research infrastructure, and unique genetic diversity position it for important contributions to understanding and treating neurodegenerative diseases. Continued investment in infrastructure and training will be essential for the region to reach its full potential.